X0306 4 2020-02-13 0 0001595893 Turning Point Therapeutics, Inc. TPTX 0001772259 Cui Jingrong Jean C/O TURNING POINT THERAPEUTICS, INC. 10628 SCIENCE CENTER DRIVE, STE. 200 SAN DIEGO CA 92121 1 0 0 0 Common Stock 1301298 D Common Stock 2020-02-13 4 S 0 200 59.83 D 792519 I By spouse Common Stock 2020-02-13 4 S 0 2400 60.70 D 790119 I By spouse Common Stock 2020-02-13 4 S 0 8800 62.18 D 781319 I By spouse Common Stock 2020-02-13 4 S 0 100 63.07 D 781219 I By spouse Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li. The weighted average sale price for the transaction reported was $59.83, and the range of prices were between $59.46 and $60.20. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $60.70, and the range of prices were between $60.47 and $61.45. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. The weighted average sale price for the transaction reported was $62.18, and the range of prices were between $61.79 and $62.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. /s/ Annette North, Attorney-in-Fact 2020-02-14